These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 11556929)

  • 1. Using an electronic medical record to identify opportunities to improve compliance with cholesterol guidelines.
    Maviglia SM; Teich JM; Fiskio J; Bates DW
    J Gen Intern Med; 2001 Aug; 16(8):531-7. PubMed ID: 11556929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efforts to improve compliance with the National Cholesterol Education Program guidelines. Results of a randomized controlled trial.
    Headrick LA; Speroff T; Pelecanos HI; Cebul RD
    Arch Intern Med; 1992 Dec; 152(12):2490-6. PubMed ID: 1456861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racial differences in compliance with NCEP-II recommendations for secondary prevention at a Veterans Affairs medical center.
    Williams ML; Morris MT; Ahmad U; Yousseff M; Li W; Ertel N;
    Ethn Dis; 2002; 12(1):S1-58-62. PubMed ID: 11913623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The reasons of poor lipid target attainment for secondary prevention in real life practice: Results from EPHESUS.
    Mert GÖ; Başaran Ö; Mert KU; Doğan V; Özlek B; Çelik O; Özlek E; Çil C; Özdemir İH; Rencüzoğulları İ; Karadeniz FÖ; Bekar L; Aktaş M; Resulzade MM; Kalçık M; Aksan G; Çinier G; Akay K; Pekel N; Şenol U; Biteker M; Kayıkçıoğlu M
    Int J Clin Pract; 2019 Sep; 73(9):1-9. PubMed ID: 31038781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-year evaluation of electronic medical record flag alerts for patients warranting secondary prevention of coronary heart disease.
    Whitley HP; Fermo JD; Chumney EC
    Pharmacotherapy; 2006 May; 26(5):682-8. PubMed ID: 16637797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physician noncompliance with the 1993 National Cholesterol Education Program (NCEP-ATPII) guidelines.
    Frolkis JP; Zyzanski SJ; Schwartz JM; Suhan PS
    Circulation; 1998 Sep; 98(9):851-5. PubMed ID: 9738639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adherence to National Cholesterol Education Program Treatment goals in postmenopausal women with heart disease. The Heart and Estrogen/Progestin Replacement Study (HERS). The HERS Research Group.
    Schrott HG; Bittner V; Vittinghoff E; Herrington DM; Hulley S
    JAMA; 1997 Apr 23-30; 277(16):1281-6. PubMed ID: 9109465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.
    Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
    J Am Coll Cardiol; 2004 Aug; 44(3):720-32. PubMed ID: 15358046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.
    Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):e149-61. PubMed ID: 15297292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ambulatory hypercholesterolemia management in patients with atherosclerosis. Gender and race differences in processes and outcomes.
    Persell SD; Maviglia SM; Bates DW; Ayanian JZ
    J Gen Intern Med; 2005 Feb; 20(2):123-30. PubMed ID: 15836544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in physician compliance with guideline on lipid profile determination within 24 h after acute myocardial infarction.
    Al Aqeel A; Mojiminiyi OA; Al Dashti R; Al Ozairi ES
    Med Princ Pract; 2005; 14(1):41-5. PubMed ID: 15608480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel, multi-ingredient supplement to manage elevated blood lipids in patients with no evidence of cardiovascular disease: a pilot study.
    Hobbs T; Caso R; McMahon D; Nymark M
    Altern Ther Health Med; 2014; 20(5):18-23. PubMed ID: 25141367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AMG 145, a monoclonal antibody against PCSK9, facilitates achievement of national cholesterol education program-adult treatment panel III low-density lipoprotein cholesterol goals among high-risk patients: an analysis from the LAPLACE-TIMI 57 trial (LDL-C assessment with PCSK9 monoclonal antibody inhibition combined with statin thErapy-thrombolysis in myocardial infarction 57).
    Desai NR; Giugliano RP; Zhou J; Kohli P; Somaratne R; Hoffman E; Liu T; Scott R; Wasserman SM; Sabatine MS
    J Am Coll Cardiol; 2014 Feb; 63(5):430-3. PubMed ID: 24161333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Achieving National Cholesterol Education Program goals for low-density lipoprotein cholesterol in cardiac patients: importance of diet, exercise, weight control, and drug therapy.
    Allison TG; Squires RW; Johnson BD; Gau GT
    Mayo Clin Proc; 1999 May; 74(5):466-73. PubMed ID: 10319076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uninsured South Florida vascular surgery patients are less likely to receive optimal medical management than their insured counterparts.
    Yeh D; Jones M; Schulman C; Karmacharya J; Velazquez OC
    J Vasc Surg; 2010 Apr; 51(4 Suppl):4S-8S. PubMed ID: 20346337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of compliance with lipid guidelines in an academic medical center.
    Schwiesow SJ; Nappi JM; Ragucci KR
    Ann Pharmacother; 2006 Jan; 40(1):27-31. PubMed ID: 16352778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Adherence to statin therapy and LDL cholesterol goal attainment in type 2 diabetics and secondary prevention patients: the role of education and knowledge].
    Yiğiner O; Ozmen N; Ozçelik F; Inanç T; Kardeşoğlu E; Uz O; Işılak Z; Aparcı M; Sahin I; Arslan E; Cebeci BS
    Turk Kardiyol Dern Ars; 2010 Dec; 38(8):544-50. PubMed ID: 21248454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implications of changing national cholesterol education program goals for the treatment and control of hypercholesterolemia.
    Persell SD; Lloyd-Jones DM; Baker DW
    J Gen Intern Med; 2006 Feb; 21(2):171-6. PubMed ID: 16390501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of rosuvastatin in low-density lipoprotein cholesterol lowering and National Cholesterol Education Program Adult Treatment Panel guideline III LDL-C goal attainment compared to other statins among diabetes mellitus patients: a retrospective study using an electronic medical records dataset in the United States.
    Fox KM; Gandhi SK; Ohsfeldt RL; Blasetto JW; Bays HE
    Curr Med Res Opin; 2007 Sep; 23(9):2125-33. PubMed ID: 17655813
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.